Shoshana Barnoy

1.8k citations

21 papers · 1.4k indexed · 1 hit paper · h-index 13

Co-authors: Jackob Moskovitz Barbara S. Berlett Wesley M. Williams Earl R. Stadtman Jesús R. Requena Malabi M. Venkatesan Thressa C. Stadtman Rodney L. Levine
Topics: Escherichia coli research studies (10 papers)Viral gastroenteritis research and epidemiology (9 papers)Clostridium difficile and Clostridium perfringens research (4 papers)
Cited by: Aging Endocrinology Biochemistry
Journals: Proceedings of the National Academy of Sciences PLoS ONE Biochemistry
Partner nations: United States Israel

In The Last Decade

Shoshana Barnoy

20 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals

2001 562 citations Jackob Moskovitz, Shoshana Barnoy et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Shoshana Barnoy

Since Specialization

Citations

This map shows the geographic impact of Shoshana Barnoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoshana Barnoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoshana Barnoy more than expected).

Fields of papers citing papers by Shoshana Barnoy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoshana Barnoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoshana Barnoy. The network helps show where Shoshana Barnoy may publish in the future.

Co-authorship network of co-authors of Shoshana Barnoy

This figure shows the co-authorship network connecting the top 25 collaborators of Shoshana Barnoy. A scholar is included among the top collaborators of Shoshana Barnoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoshana Barnoy. Shoshana Barnoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in mice 2025 ·Vaccine ·(unknown),Jane M. Michalski,(unknown),Hyojik Yang,Lakshmi Chandrasekaran,Timothy R. O’Meara,David J. Dowling,Ofer Levy,Shoshana Barnoy,Malabi M. Venkatesan,Robert K. Ernst	0
2	Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding 2021 ·PLoS ONE ·Malabi M. Venkatesan,(unknown),Shoshana Barnoy,Monica McNeal,Jill El-Khorazaty,Robert W. Frenck,Shahida Baqar	4
3	A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei 2018 ·Vaccine ·Robert W. Frenck,Shahida Baqar,William Alexander,Michelle Dickey,Monica McNeal,Jill El-Khorazaty,(unknown),(unknown),Shoshana Barnoy,Akamol E. Suvarnapunya,Robert W. Kaminski,Malabi M. Venkatesan	31
4	TheGalleria mellonellalarvae as anin vivomodel for evaluation ofShigellavirulence 2017 ·Gut Microbes ·Shoshana Barnoy,Hanan Gancz,Yuewei Zhu,Cary L. Honnold,Daniel V. Zurawski,Malabi M. Venkatesan	49
5	Oral administration of live Shigella vaccine candidates in rhesus monkeys show no evidence of competition for colonization and immunogenicity between different serotypes 2014 ·Vaccine ·Ryan T. Ranallo,Robert W. Kaminski,Shahida Baqar,Moumita Dutta,Luis A. Lugo‐Roman,(unknown),Shoshana Barnoy,Malabi M. Venkatesan	9
6	Evaluation of virulent and live Shigella sonnei vaccine candidates in a gnotobiotic piglet model 2013 ·Vaccine ·Kwang‐il Jeong,Malabi M. Venkatesan,Shoshana Barnoy,Saul Tzipori	9
7	Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection 2011 ·Vaccine ·Shoshana Barnoy,Shahida Baqar,Robert W. Kaminski,(unknown),(unknown),Thomas L. Hale,Ryan T. Ranallo,Malabi M. Venkatesan	25
8	Further characterization ofShigella sonneilive vaccine candidates WRSs2 and WRSs3-plasmid composition, invasion assays and Sereny reactions 2011 ·Gut Microbes ·(unknown),(unknown),(unknown),Ryan T. Ranallo,Akamol E. Suvarnapunya,James E. Lee,Shoshana Barnoy,Malabi M. Venkatesan	10
9	Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity 2009 ·Vaccine ·Shoshana Barnoy,(unknown),Richard F. Helm,Akamol E. Suvarnapunya,Ryan T. Ranallo,Saul Tzipori,Malabi M. Venkatesan	36
10	Microbial Pathogen-Induced Necrotic Cell Death Mediated by the Inflammasome Components CIAS1/Cryopyrin/NLRP3 and ASC 2007 ·Cell Host & Microbe ·Stephen B. Willingham,Dan T. Bergstralh,William O’Connor,Amy C. Morrison,Debra J. Taxman,Joseph A. Duncan,Shoshana Barnoy,Malabi M. Venkatesan,Richard A. Flavell,Mohanish Deshmukh,Hal M. Hoffman,Jenny P.‐Y. Ting	234
11	Developing liveShigellavaccines using Î» Red recombineering 2006 ·FEMS Immunology & Medical Microbiology ·Ryan T. Ranallo,Shoshana Barnoy,(unknown),(unknown),Malabi M. Venkatesan	55
12	Mouse methionine sulfoxide reductase B: effect of selenocysteine incorporation on its activity and expression of the seleno-containing enzyme in bacterial and mammalian cells 2002 ·Biochemical and Biophysical Research Communications ·Shoshana Barnoy,Jackob Moskovitz	48
13	Role for Phospholipid Interactions in the Trafficking Defect of ΔF508-CFTR 2002 ·Biochemistry ·Ofer Eidelman,Shoshana Barnoy,Michal Razin,Jiang Zhang,Peter McPhie,George Lee,(unknown),Eric J. Sorscher,Harvey B. Pollard	18
14	Overexpression of wild type and SeCys/Cys mutant of human thioredoxin reductase in E. coli: the role of selenocysteine in the catalytic activity 2001 ·Free Radical Biology and Medicine ·Shoshana Barnoy,Sergey Gorlatov,Thressa C. Stadtman	35
15	Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammalsbreakdown → 2001 ·Proceedings of the National Academy of Sciences ·Jackob Moskovitz,Shoshana Barnoy,Wesley M. Williams,Jesús R. Requena,Barbara S. Berlett,Earl R. Stadtman	562
16	Mammalian thioredoxin reductase: Oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity 2000 ·Proceedings of the National Academy of Sciences ·(unknown),Shoshana Barnoy,Jaeyul Kwon,Rodney L. Levine,Thressa C. Stadtman,Sue Goo Rhee	213
17	A1 Receptor Antagonist 8-Cyclopentyl-1,3-dipropylxanthine Selectively Activates Chloride Efflux from Human Epithelial and Mouse Fibroblast Cell Lines Expressing the Cystic Fibrosis Transmembrane Regulator .DELTA.F508 Mutation 1995 ·Biochemistry ·(unknown),Kenneth A. Jacobson,Shoshana Barnoy,Z. Ioav Cabantchik,William B. Guggino,Pamela L. Zeitlin,R. James Turner,(unknown),Ofer Eidelman,Harvey B. Pollard	50
18	Transport domain of the erythrocyte anion exchange protein 1990 ·The Journal of Membrane Biology ·Shoshana Barnoy,Z. Ioav Cabantchik	12
19	Oriented reconstitution of red cell membrane proteins and assessment of their transmembrane disposition by immunoquenching of fluorescence 1985 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·(unknown),Shoshana Barnoy,Hagai Ginsburg,Z. Ioav Cabantchik	10
20	Orientation of transmembrane polypeptides as revealed by antibody quenching of fluorescence 1984 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Shoshana Barnoy,(unknown),Hagai Ginsburg,Z. Ioav Cabantchik	6

About Shoshana Barnoy

Shoshana Barnoy is a scholar working on Endocrinology, Aging and Infectious Diseases, having authored 21 papers that have together received 1.4k indexed citations. Recurring topics across this work include Escherichia coli research studies (10 papers), Viral gastroenteritis research and epidemiology (9 papers) and Clostridium difficile and Clostridium perfringens research (4 papers). The work is most often cited by research in Aging (89 citations), Endocrinology (170 citations) and Biochemistry (148 citations). Shoshana Barnoy has collaborated with scholars based in United States and Israel. Frequent co-authors include Jackob Moskovitz, Barbara S. Berlett, Wesley M. Williams, Earl R. Stadtman, Jesús R. Requena, Malabi M. Venkatesan, Thressa C. Stadtman, Rodney L. Levine, Sue Goo Rhee and Jaeyul Kwon. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact